Polpharma Biologics and Tuteur have signed a licensing agreement for biosimilars for autoimmune diseases.

Porpharma Biologics, a biopharmaceutical company specializing in the development and manufacture of biosimilars, today announced a groundbreaking licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will acquire exclusive commercialization rights for biosimilars for autoimmune diseases in Latin America…












